A new platform to monitor patients during opioid addiction treatment
Development of the OpiAID strength band platform
This study is testing a new digital tool called the OpiAID Strength Band, which helps doctors keep track of how patients are doing during their treatment for opioid use disorder by monitoring their activity and withdrawal symptoms, making it easier to adjust their care and support them better.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Opiaid, INC. NIH-funded |
| Lab location | 1 site (Wilmington, United States) |
| Project ID | NIH-11284129 on NIH RePORTER |
What this research studies
This research focuses on developing the OpiAID Strength Band Platform, an innovative digital tool designed to monitor patients undergoing medication-assisted treatment for opioid use disorder. By utilizing artificial intelligence and accelerometry, the platform aims to provide real-time data on patient activity and withdrawal symptoms, helping healthcare providers adjust treatment plans more effectively. The goal is to improve patient retention during the critical induction phase of treatment, where proper dosing of opioid agonists is essential for success. This approach seeks to enhance the overall management of opioid dependence and reduce the risk of relapse.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing medication-assisted treatment for opioid use disorder, particularly during the induction phase.
Not a fit: Patients who are not currently seeking treatment for opioid use disorder or those who are not eligible for medication-assisted treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment protocols for patients struggling with opioid addiction, ultimately reducing relapse rates and improving recovery outcomes.
How similar studies have performed: Other research has shown promise in using digital monitoring tools for addiction treatment, indicating that this approach could be effective.
Where this research is happening
Wilmington, United States
- Opiaid, INC. — Wilmington, United States (Active)
Researchers
- Principal investigator: Reeser, David — Opiaid, INC.
- Study coordinator: Reeser, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.